BackPDL Biopharma Overview

PDL Biopharma Other Liabilities

PDL Biopharma's other liabilities is $27M.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$27.37M

Peer average

Loading

PDL Biopharma Other Liabilities History

Loading

PDL Biopharma vs. peers: Other Liabilities Comparison

Loading

PDL Biopharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PDL Biopharma (PDLI) FAQ

PDL Biopharma (PDLI) currently reports a other liabilities of $27M as of September 2020. In the prior-year period, the figure was $0. Use the charts on this page to explore PDL Biopharma's other liabilities history and peer comparisons.

PDL Biopharma's other liabilities changed from $0 to $27M (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PDL Biopharma reported $27M in other liabilities as of September 2020. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $27M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PDL Biopharma, and consider following PDLI for alerts when major investors trade the stock.

PDL Biopharma is classified in the Healthcare sector. On other liabilities, it currently shows $27M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PDLI with unrelated industries.